Latest Kantar Health Stories
CIPP/E is the global standard in privacy protection. New York, NY (PRWEB) January 27, 2015 Kantar
New report from Kantar Health shows opportunities for biosimilars are high in oncology, low in rheumatoid arthritis in China. Shanghai, China (PRWEB) December
New research from Kantar Health’s National Health and Wellness Survey shows that indirect and direct costs due to health increase as BMI increases. New York,
New research from Kantar Health’s National Health and Wellness Survey shows European patients with macular edema are more likely to use insulin and have been diagnosed longer. New
Move extends company's clinical, real-world research and health outcomes capabilities New York, NY (PRWEB) September 15, 2014
PINNAKLE uncovers unrealized brand opportunity in the pharma industry. New York, NY (PRWEB) June 24, 2014 Kantar
New results from the National Health and Wellness Survey show patients with type 2 diabetes who are aware of HbA1c levels are more likely to have diabetic complications. New
New results from the National Health and Wellness Survey show non-adherence is associated with greater work and activity impairment. New York, NY (PRWEB) June
Brody will lead Kantar Health’s partnerships and acquisitions activities. New York, NY (PRWEB) April 16, 2014
New findings from PainMPact™ show high unmet need globally by patients due to low diagnosis and low treatment satisfaction. New York, NY (PRWEB) March 25,
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.